Cargando…

Perceptions from pharmaceutical stakeholders on how the pharmaceutical budget is allocated in South Africa

BACKGROUND: South Africa faces a heavy burden of disease, which impacts resource allocation. The needs of South Africa require efficient translation into pharmaceutical expenditure for medicine provision, to ensure availability of medicines. Given that South Africa faces various challenges with medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moodley, Lirosha, Suleman, Fatima, Perumal-Pillay, Velisha Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453029/ https://www.ncbi.nlm.nih.gov/pubmed/34548094 http://dx.doi.org/10.1186/s40545-021-00362-3

Ejemplares similares

Parents’ and guardians’ perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa – a qualitative study
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

Understanding the decision making process of selection of medicines in the private sector in South Africa – lessons for low-middle income countries
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2020)

Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance
por: Perumal-Pillay, Velisha A., et al.
Publicado: (2021)

Quantitative evaluation of essential medicines lists: the South African case study
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2016)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
por: Bojuwoye, Adetola Olaniyi, et al.
Publicado: (2022)

Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities
por: Govender, Tashni, et al.
Publicado: (2021)

The availability of priority medicines for children under 5 years in eThekwini, South Africa
por: Mahadeo, Shannice, et al.
Publicado: (2022)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

Extending Pharmacist Roles in Primary Healthcare to Meet the Needs of Universal Health Coverage in Zimbabwe: A Pharmacist Perspective and Curriculum Evaluation
por: Chiutsi, Douglas, et al.
Publicado: (2022)

Evaluating the effect of a proposed logistics fee cap on pharmaceuticals in South Africa - a pre and post analysis
por: Bangalee, Varsha, et al.
Publicado: (2015)

What variables should be considered in allocating Primary health care Pharmaceutical budgets to districts in Uganda?
por: Mujasi, Paschal N, et al.
Publicado: (2015)

Predictors of primary health care pharmaceutical expenditure by districts in Uganda and implications for budget setting and allocation
por: Mujasi, Paschal N., et al.
Publicado: (2015)

To evaluate the impact of opening up ownership of pharmacies in South Africa
por: Moodley, Rajatheran, et al.
Publicado: (2020)

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry
por: Jandhyala, Ravi
Publicado: (2022)

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
por: Shobeiri, Nikta, et al.
Publicado: (2022)

Burning Questions: What Should the Pharmacist Know about Managing Minor Burns?
por: Wall, Shelley, et al.
Publicado: (2022)

The Dutch chain approach on pharmaceuticals in water: Stakeholders acting together to reduce the environmental impact of pharmaceuticals
por: Moermond, Caroline T. A., et al.
Publicado: (2022)

Stakeholder perspectives on the ethico-legal dimensions of biobanking in South Africa
por: Singh, Shenuka, et al.
Publicado: (2021)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Comparison of patient satisfaction with pharmaceutical services of postal pharmacy and community pharmacy
por: Govender, Nishern, et al.
Publicado: (2019)

Supporting the production of pharmaceuticals in Africa
por: Dong, Jicui, et al.
Publicado: (2016)

The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014
por: Moodley, Rajatheran, et al.
Publicado: (2019)

Optimal reliability allocation of heterogeneous components in pharmaceutical production plant
por: Aqel, Ibrahim, et al.
Publicado: (2023)

Pharmaceuticals and modern statecraft in South Africa: the cases of opium, thalidomide and contraception.
por: Parle, Julie, et al.
Publicado: (2018)

Household Pharmaceutical Waste Management Practices in the Johannesburg Area, South Africa
por: Magagula, Benele K., et al.
Publicado: (2022)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey
por: Sanwald, Alice, et al.
Publicado: (2016)

Rules of engagement: perspectives on stakeholder engagement for genomic biobanking research in South Africa
por: Staunton, Ciara, et al.
Publicado: (2018)

Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products
por: Toghanian, Samira, et al.
Publicado: (2022)

Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry
por: Horner, Rory
Publicado: (2021)

Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs
por: Kalkman, Shona, et al.
Publicado: (2016)

Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
por: Rizk, Hoda Ibrahim, et al.
Publicado: (2021)

What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?
por: Moodley, Keymanthri, et al.
Publicado: (2021)

Perceptions and factors affecting pharmaceutical market access: results from a literature review and survey of stakeholders in different settings
por: Sendyona, Semukaya, et al.
Publicado: (2016)

Treatment and disposal practices of pharmaceutical effluent containing potential antibiotic residues in two states in India and perceptions of various stakeholders on contribution of pharmaceutical effluent to antimicrobial resistance: a qualitative study
por: Kotwani, Anita, et al.
Publicado: (2023)

Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States
por: Mendola, Nicholas D, et al.
Publicado: (2022)

The Impact of Global Budgets on Pharmaceutical Spending and Utilization: Early Experience From the Alternative Quality Contract
por: Afendulis, Christopher C., et al.
Publicado: (2014)

New Medicine Service by Community Pharmacists: An Opportunity to Enhance Universal Health Coverage at a Primary Health Level in South Africa
por: Naidoo, Vivian, et al.
Publicado: (2023)

The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa
por: Mabuka, Thabo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33u7lanbaaktdh4kkpfcpec00k